CABA
Price
$1.20
Change
-$0.04 (-3.23%)
Updated
Apr 3, 02:32 PM (EDT)
Capitalization
62.92M
41 days until earnings call
IMNM
Price
$6.28
Change
-$0.43 (-6.41%)
Updated
Apr 3, 02:44 PM (EDT)
Capitalization
583.44M
35 days until earnings call
Ad is loading...

CABA vs IMNM

Header iconCABA vs IMNM Comparison
Open Charts CABA vs IMNMBanner chart's image
Cabaletta Bio
Price$1.20
Change-$0.04 (-3.23%)
Volume$100
Capitalization62.92M
Immunome
Price$6.28
Change-$0.43 (-6.41%)
Volume$2.08K
Capitalization583.44M
CABA vs IMNM Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. IMNM commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and IMNM is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CABA: $1.24 vs. IMNM: $6.71)
Brand notoriety: CABA and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 125% vs. IMNM: 107%
Market capitalization -- CABA: $62.92M vs. IMNM: $583.44M
CABA [@Biotechnology] is valued at $62.92M. IMNM’s [@Biotechnology] market capitalization is $583.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both CABA and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 4 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 4 bearish.
  • IMNM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CABA and IMNM are a good buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а -21.02% price change this week, while IMNM (@Biotechnology) price change was -5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

Reported Earning Dates

CABA is expected to report earnings on May 14, 2025.

IMNM is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($583M) has a higher market cap than CABA($62.9M). IMNM YTD gains are higher at: -36.817 vs. CABA (-45.374). IMNM (-109.95M) and CABA (-112.92M) have comparable annual earnings (EBITDA) . IMNM has more cash in the bank: 240M vs. CABA (183M). IMNM has less debt than CABA: IMNM (2.72M) vs CABA (15.2M). IMNM has higher revenues than CABA: IMNM (10.1M) vs CABA (0).
CABAIMNMCABA / IMNM
Capitalization62.9M583M11%
EBITDA-112.92M-109.95M103%
Gain YTD-45.374-36.817123%
P/E RatioN/AN/A-
Revenue010.1M-
Total Cash183M240M76%
Total Debt15.2M2.72M559%
TECHNICAL ANALYSIS
Technical Analysis
CABAIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 23 days ago
88%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVAIX6.26N/A
N/A
Federated Hermes Strategic Value Div IS
FSOAX39.79N/A
N/A
Fidelity Advisor Value Strategies A
STMSX21.55N/A
N/A
SEI Tax-Managed Small/Mid Cap F (SIMT)
DEQAX13.59N/A
N/A
BNY Mellon Global Equity Income - A
STRLX55.82N/A
N/A
Sterling Capital MdCp Relatv Val A

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+5.98%
KYTX - CABA
47%
Loosely correlated
+8.59%
ARWR - CABA
44%
Loosely correlated
+3.97%
IMNM - CABA
41%
Loosely correlated
+7.19%
AUTL - CABA
38%
Loosely correlated
+11.35%
IPSC - CABA
38%
Loosely correlated
+3.96%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+7.19%
KYMR - IMNM
52%
Loosely correlated
+4.46%
IDYA - IMNM
50%
Loosely correlated
+10.70%
BEAM - IMNM
49%
Loosely correlated
+4.79%
ADVM - IMNM
48%
Loosely correlated
+11.23%
RXRX - IMNM
48%
Loosely correlated
+3.83%
More